We are live on ! Find out more
TCOV

Trust Company of Vermont Portfolio holdings

AUM $2.68B
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.2B
AUM Growth
+$42.5M
Cap. Flow
+$2.61M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.99%
Holding
1,087
New
93
Increased
215
Reduced
205
Closed
49

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.6M
2
BND icon
Vanguard Total Bond Market
BND
+$1.2M
3
MSM icon
MSC Industrial Direct
MSM
+$832K
4
AMAT icon
Applied Materials
AMAT
+$793K
5
JPM icon
JPMorgan Chase
JPM
+$775K

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.18M
2
DD icon
DuPont de Nemours
DD
+$810K
3
FDX icon
FedEx
FDX
+$681K
4
XOM icon
ExxonMobil
XOM
+$545K
5
WFC icon
Wells Fargo
WFC
+$517K

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 13.27%
3 Healthcare 13.2%
4 Industrials 11.18%
5 Consumer Staples 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DOW icon
201
Dow Inc
DOW
$22.1B
$620K 0.05%
+12,586
New +$664K
LBTYK icon
202
Liberty Global Class C
LBTYK
$3.46B
$610K 0.05%
23,000
-800
-3% -$20.5K
CI icon
203
Cigna
CI
$73.3B
$597K 0.05%
3,788
+435
+13% +$68.2K
XBI icon
204
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$597K 0.05%
6,810
+856
+14% +$73K
IP icon
205
International Paper
IP
$21.8B
$579K 0.05%
14,128
-1,023
-7% -$43.3K
MKL icon
206
Markel Group
MKL
$22.8B
$570K 0.05%
523
– –
PARA
207
DELISTED
Paramount Global Class B
PARA
$570K 0.05%
11,424
+8,963
+364% +$444K
NVO
208
Novo Nordisk
NVO
$203B
$561K 0.05%
21,986
-1,900
-8% -$47K
AZO icon
209
AutoZone
AZO
$49.7B
$550K 0.05%
500
– –
RDS.B
210
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$533K 0.04%
8,106
-68
-0.8% -$4.42K
AVA icon
211
Avista
AVA
$3.23B
$525K 0.04%
11,770
-900
-7% -$38.3K
CMI icon
212
Cummins
CMI
$87.8B
$522K 0.04%
3,051
+133
+5% +$21.8K
GLIBA
213
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
$503K 0.04%
8,190
– –
OKE icon
214
Oneok
OKE
$58.3B
$485K 0.04%
7,058
+21
+0.3% +$1.42K
ZBH icon
215
Zimmer Biomet
ZBH
$18.7B
$481K 0.04%
4,202
+342
+9% +$40.1K
GWR
216
DELISTED
Genesee & Wyoming Inc.
GWR
$480K 0.04%
4,800
– –
SNEX icon
217
StoneX
SNEX
$8.37B
$477K 0.04%
61,003
-709
-1% -$5.29K
INGR icon
218
Ingredion
INGR
$6.54B
$471K 0.04%
5,714
+960
+20% +$82.5K
RSP icon
219
Invesco S&P 500 Equal Weight ETF
RSP
$99.5B
$470K 0.04%
4,357
+1,473
+51% +$156K
VTI icon
220
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$468K 0.04%
3,117
– –
CBU icon
221
Community Bank
CBU
$3.43B
$461K 0.04%
6,994
– –
GLD icon
222
SPDR Gold Trust
GLD
$144B
$460K 0.04%
3,454
-754
-18% -$93.2K
PBD icon
223
Invesco Global Clean Energy ETF
PBD
$195M
$459K 0.04%
36,545
-2,507
-6% -$30.7K
MPC icon
224
Marathon Petroleum
MPC
$97.8B
$456K 0.04%
8,154
+21
+0.3% +$1.15K
AWK icon
225
American Water Works
AWK
$26.8B
$454K 0.04%
3,911
+65
+2% +$7.17K
7 8
9
10 11

Similar funds

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
TCAM
Turtle Creek Asset Management Toronto, Ontario, Canada $2.67B AUM 0.64% 1-Year Est. Return
SFI
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $2.67B AUM 21.74% 1-Year Est. Return
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
HCM
Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.57% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return

Trust Company of Vermont's Q2 2019 Portfolio in Review

As of Q2 2019, Trust Company of Vermont held 1,087 positions worth $1.2B, up 3.7% from $1.16B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Trust Company of Vermont's Q2 2019 filing shows 93 new, 215 increased, 205 reduced and 49 closed positions. Its largest new stake was Dow Inc: 12,586 shares worth $620K. The largest sale was Novartis, an estimated $1.18M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

  • Trust Company of Vermont's largest Q2 2019 buy was Dow Inc: 12,586 shares worth $620K.
  • Trust Company of Vermont added most to CVS Health in Q2 2019, an estimated $1.6M increase.
  • Trust Company of Vermont's biggest Q2 2019 reduction was Novartis, cutting an estimated $1.18M.
  • Trust Company of Vermont fully exited Bemis in Q2 2019, selling an estimated $353K.
  • Trust Company of Vermont's ten largest holdings make up 20% of its $1.2B portfolio in Q2 2019.
  • Trust Company of Vermont opened 93 new positions and closed 49 in Q2 2019.
  • Trust Company of Vermont's portfolio value rose 3.7% quarter-over-quarter to $1.2B.

Based on Trust Company of Vermont's 13F filing for Q2 2019, filed 26 Jul 2019.